{"success":true,"data":{"pressRelease":{"id":"115347","rtpr_id":"nPn9mfr2Pa","ticker":"ABBV","exchange":"NYSE","all_tickers":["ABBV"],"title":"Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices","author":"PR Newswire","published_at":"2026-08-11T12:00:13.535Z","article_body":"Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices\n\nPR Newswire\n\nIRVINE, Calif., Aug. 11, 2026\n\n * Updated program delivers simplified savings, greater benefits transparency,\nand expanded opportunities for practice growth\n * Introduces new rewards opportunities for customer segments, including\nfirst-time APP members, growing practices, and long-standing loyal customers\nIRVINE, Calif., Aug. 11, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie\ncompany, today announced updates to Allergan Partner Privileges(®) (APP), its\ncustomer portfolio loyalty program, designed to better support the way today's\naesthetics practices operate and grow. Shaped by customer feedback and market\nmomentum, the program now introduces simpler savings, greater benefits\ntransparency and expanded opportunities for practice growth, making it easier\nfor customers to understand, access and maximize the value of their\npartnership with Allergan Aesthetics.\n\n\"The needs of today's aesthetics practices continue to evolve, and so should\nthe programs designed to support them,\" said Nicole Mowad-Nassar, Senior Vice\nPresident, AbbVie and President, Global Allergan Aesthetics. \"Our customers\ntold us they wanted greater simplicity, more transparency and rewards that\nbetter reflect the way they operate and grow their businesses. We've invested\nin these program updates to create even more opportunities for our customers\nto realize the value of partnering with Allergan Aesthetics.\"\n\nBenefits That Grow with Your Practice\n\nThe APP program updates are built around the areas customers cited as\nbeneficial to running their businesses:\n\n * Simplified Savings: The updated program streamlines Brand Tiers and introduces\na simplified pricing discount structure designed to make savings easier to\nunderstand and access. More Allergan Aesthetics products contribute to each\nBrand Tier, helping customers unlock benefits sooner.\n * Greater Transparency: Customers can now more easily see and understand their\nprogram benefits. Net pricing is clearly visible at the time of ordering and\nreflects savings based on loyalty benefits earned through APP status.\nPractices can also track APP status and upgrade progress in real time.\n * Rewarding Growth: New Portfolio Levels reward growth across the Allergan\nAesthetics portfolio and allow customers to begin earning pricing benefits\nsooner, based on purchasing volume. Eligible purchases across the portfolio\ncount toward higher APP discounts, helping practices unlock greater benefits\nas they grow. New rewards benefits are available for specific customer\nsegments, including first-time APP members, growing practices, and\nlong-standing loyal customers.\nAdditional BOTOX(®) Cosmetic Growth Benefit\n\nAllergan Aesthetics is also introducing a new BOTOX(®) Cosmetic\n(onabotulinumtoxinA) Growth Benefit for eligible customers that recognizes\npractices achieving qualifying quarterly growth by providing a quarterly\nrebate on eligible BOTOX(®) Cosmetic purchases. The Growth Benefit is\ndesigned as an additional way to support customer growth and strengthen\npartnership with Allergan Aesthetics.\n\nAbout Allergan Partner Privileges(®\n)APP is the customer portfolio loyalty program by Allergan Aesthetics designed\nto reward and empower aesthetics practices. Through APP, customers can earn\nsavings, rewards, and benefits across the Allergan Aesthetics portfolio while\ngrowing their business with a trusted industry partner.\n\nAbout Allergan Aesthetics\nAt Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market\na portfolio of leading aesthetics brands and products. Our aesthetics\nportfolio includes facial injectables, body contouring, plastics, skin care,\nand more. Our goal is to consistently provide our customers with innovation,\neducation, exceptional service, and a commitment to excellence, all with a\npersonal touch. For more information, visit www.allerganaesthetics.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=1081228776&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4706707-1%26h%3D1904554432%26u%3Dhttps%253A%252F%252Fedge.prnewswire.com%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4606759-1%2526h%253D1506431868%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D4354416-1%252526h%25253D2203297917%252526u%25253Dhttps%2525253A%2525252F%2525252Fc212.net%2525252Fc%2525252Flink%2525252F%2525253Ft%2525253D0%25252526l%2525253Den%25252526o%2525253D4147252-1%25252526h%2525253D3391859501%25252526u%2525253Dhttp%252525253A%252525252F%252525252Fwww.allerganaesthetics.com%252525252F%25252526a%2525253Dwww.allerganaesthetics.com%252526a%25253Dwww.allerganaesthetics.com%2526a%253Dwww.allerganaesthetics.com%26a%3Dwww.allerganaesthetics.com&a=www.allerganaesthetics.com)\n.\n\nAbout AbbVie\nAbbVie's mission is to discover and deliver innovative medicines and solutions\nthat solve serious health issues today and address the medical challenges of\ntomorrow. We strive to have a remarkable impact on people's lives across\nseveral key therapeutic areas including immunology, neuroscience and oncology\n– and products and services in our Allergan Aesthetics portfolio. For more\ninformation about AbbVie, please visit us at www.abbvie.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=2855392446&u=http%3A%2F%2Fwww.abbvie.com%2F&a=www.abbvie.com)\n. Follow @abbvie on LinkedIn,\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=3248653038&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fabbvie%2F&a=LinkedIn%2C)\n Facebook\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=2692782220&u=https%3A%2F%2Fwww.facebook.com%2FAbbVieGlobal%2F&a=Facebook)\n, Instagram\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=4238858922&u=https%3A%2F%2Fwww.instagram.com%2Fabbvie%2F&a=Instagram)\n, X\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=2737110622&u=https%3A%2F%2Ftwitter.com%2Fabbvie&a=X)\n and YouTube.\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=302839011&u=https%3A%2F%2Fwww.youtube.com%2Fuser%2FAbbVie&a=YouTube.)\n\nApproved Uses\nBOTOX(®) Cosmetic is a prescription medicine that is injected into muscles\nand used to temporarily improve the look of moderate to severe forehead lines,\ncrow's feet lines, frown lines between the eyebrows, and vertical bands\nconnecting the jaw and neck (platysma bands) in adults.\n\nFor more information, refer to the Medication Guide or talk with your doctor.\nTo report a side effect, please call Allergan Aesthetics at 1-800-678-1605.\n\nSee BOTOX(®) Cosmetic full Product Information\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=583908942&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4658012-1%26h%3D82476651%26u%3Dhttps%253A%252F%252Fwww.rxabbvie.com%252Fpdf%252Fbotox-cosmetic_pi.pdf%26a%3DProduct%2BInformation&a=Product+Information)\n, including Boxed Warning and Medication Guide\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=140212173&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4658012-1%26h%3D2073419461%26u%3Dhttps%253A%252F%252Fwww.rxabbvie.com%252Fpdf%252Fbotox_medguide.pdf%26a%3DMedication%2BGuide&a=Medication+Guide)\n.\n\nIMPORTANT SAFETY INFORMATION\nBOTOX(®) Cosmetic may cause serious side effects that can be life\nthreatening. Get medical help right away if you have any of these problems any\ntime (hours to weeks) after injection of BOTOX(®) Cosmetic:\n\n * Problems swallowing, speaking, or breathing, due to weakening of associated\nmuscles, which can be severe and result in loss of life. You are at the\nhighest risk if these problems are preexisting before injection. Swallowing\nproblems may last for several months.\n * Spread of toxin effects. The effect of botulinum toxin may affect areas away\nfrom the injection site and cause serious symptoms, including loss of strength\nand all-over muscle weakness, double vision, blurred vision and drooping\neyelids, hoarseness or change or loss of voice, trouble saying words clearly,\nloss of bladder control, trouble breathing, and trouble swallowing.\nBOTOX(®) Cosmetic dosing units are not the same as, or comparable to, any\nother botulinum toxin product.\n\nThere has not been a confirmed serious case of spread of toxin effect when\nBOTOX(®) Cosmetic has been used at the recommended dose to treat frown lines,\ncrow's feet lines, forehead lines, and/or platysma bands.\n\nBOTOX(®) Cosmetic may cause loss of strength or general muscle weakness,\nvision problems, or dizziness within hours to weeks of receiving BOTOX(®)\nCosmetic. If this happens, do not drive a car, operate machinery, or do other\ndangerous activities.\n\nSerious and/or immediate allergic reactions have been reported, including\nitching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or\nfeeling faint. Get medical help right away if you are wheezing or have asthma\nsymptoms, or if you become dizzy or faint.\n\nDo not receive BOTOX(®) Cosmetic if you are allergic to any of the\ningredients in BOTOX(®) Cosmetic (see Medication Guide for ingredients); had\nan allergic reaction to any other botulinum toxin product such as Myobloc\n(rimabotulinumtoxinB), Dysport (abobotulinumtoxinA), Xeomin\n(incobotulinumtoxinA), Jeuveau (prabotulinumtoxinA-xvfs), Daxxify\n(daxibotulinumtoxinA-lanm), or Letybo (letibotulinumtoxinA-wlbg); or have a\nskin infection at the planned injection site. This list may not include all\navailable botulinum toxin products.\n\nTell your doctor about all your muscle or nerve conditions, such as ALS or\nLou Gehrig's disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may\nbe at increased risk of serious side effects, including difficulty swallowing\nand difficulty breathing, from standard doses of BOTOX(®) Cosmetic.\n\nTell your doctor about all your medical conditions, including surgery or plans\nto have surgery on your face, trouble raising your eyebrows, drooping eyelids,\nany other abnormal facial change, are pregnant or plan to become pregnant (it\nis not known if BOTOX(®) Cosmetic can harm your unborn baby), or are\nbreastfeeding or plan to (it is not known if BOTOX(®) Cosmetic passes into\nbreast milk).\n\nTell your doctor about all the medicines you take, including prescription and\nover-the-counter medicines, vitamins, and herbal supplements. Using BOTOX(®)\nCosmetic with certain other medicines may cause serious side effects. Do not\nstart any new medicines until you have told your doctor that you have received\nBOTOX(®) Cosmetic in the past.\n\nTell your doctor if you have received any other botulinum toxin product in the\nlast 4 months; have received injections of botulinum toxin such as Myobloc,\nDysport, Xeomin, Jeuveau, Daxxify, or Letybo in the past (tell your doctor\nexactly which product you received); have recently received an antibiotic by\ninjection; take muscle relaxants; take an allergy or cold medicine; take a\nsleep medicine; or take aspirin-like products or blood thinners.\n\nOther side effects of BOTOX(®) Cosmetic include dry mouth; discomfort or\npain at the injection site; tiredness; headache; neck pain; and eye problems,\nincluding double vision, blurred vision, decreased eyesight, drooping eyelids\nand eyebrows, swelling of eyelids, and dry eyes.\n\nForward-Looking Statements\nSome statements in this news release are, or may be considered,\nforward-looking statements for purposes of the Private Securities Litigation\nReform Act of 1995. The words \"believe,\" \"expect,\" \"anticipate,\" \"project\" and\nsimilar expressions and uses of future or conditional verbs, generally\nidentify forward-looking statements. AbbVie cautions that these\nforward-looking statements are subject to risks and uncertainties that may\ncause actual results to differ materially from those expressed or implied in\nthe forward-looking statements. Such risks and uncertainties include, but are\nnot limited to, challenges to intellectual property, competition from other\nproducts, difficulties inherent in the research and development process,\nadverse litigation or government action, changes to laws and regulations\napplicable to our industry, the impact of global macroeconomic factors, such\nas economic downturns or uncertainty, international conflict, trade disputes\nand tariffs, and other uncertainties and risks associated with global business\noperations. Additional information about the economic, competitive,\ngovernmental, technological and other factors that may affect AbbVie's\noperations is set forth in Item 1A, \"Risk Factors,\" of AbbVie's 2025 Annual\nReport on Form 10-K, which has been filed with the Securities and Exchange\nCommission, as updated by its Quarterly Reports on Form 10-Q and in other\ndocuments that AbbVie subsequently files with the Securities and Exchange\nCommission that update, supplement or supersede such information. AbbVie\nundertakes no obligation, and specifically declines, to release publicly any\nrevisions to forward-looking statements as a result of subsequent events or\ndevelopments, except as required by law.\n\nU.S. Media:\nAdelle Infante, Corporate Communications\nadelle.infante@allergan.com (mailto:adelle.infante@allergan.com)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/allergan-aesthetics-refreshes-allergan-partner-privileges-to-better-support-todays-modern-aesthetics-practices-302847863.html\n(https://www.prnewswire.com/news-releases/allergan-aesthetics-refreshes-allergan-partner-privileges-to-better-support-todays-modern-aesthetics-practices-302847863.html)\n\nSOURCE AbbVie\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn9mfr2Pa","title":"Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices","author":"PR Newswire","ticker":"ABBV","created":"2026-08-11T12:00:13.535Z","tickers":["ABBV"],"exchange":"NYSE","article_body":"Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices\n\nPR Newswire\n\nIRVINE, Calif., Aug. 11, 2026\n\n * Updated program delivers simplified savings, greater benefits transparency,\nand expanded opportunities for practice growth\n * Introduces new rewards opportunities for customer segments, including\nfirst-time APP members, growing practices, and long-standing loyal customers\nIRVINE, Calif., Aug. 11, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie\ncompany, today announced updates to Allergan Partner Privileges(®) (APP), its\ncustomer portfolio loyalty program, designed to better support the way today's\naesthetics practices operate and grow. Shaped by customer feedback and market\nmomentum, the program now introduces simpler savings, greater benefits\ntransparency and expanded opportunities for practice growth, making it easier\nfor customers to understand, access and maximize the value of their\npartnership with Allergan Aesthetics.\n\n\"The needs of today's aesthetics practices continue to evolve, and so should\nthe programs designed to support them,\" said Nicole Mowad-Nassar, Senior Vice\nPresident, AbbVie and President, Global Allergan Aesthetics. \"Our customers\ntold us they wanted greater simplicity, more transparency and rewards that\nbetter reflect the way they operate and grow their businesses. We've invested\nin these program updates to create even more opportunities for our customers\nto realize the value of partnering with Allergan Aesthetics.\"\n\nBenefits That Grow with Your Practice\n\nThe APP program updates are built around the areas customers cited as\nbeneficial to running their businesses:\n\n * Simplified Savings: The updated program streamlines Brand Tiers and introduces\na simplified pricing discount structure designed to make savings easier to\nunderstand and access. More Allergan Aesthetics products contribute to each\nBrand Tier, helping customers unlock benefits sooner.\n * Greater Transparency: Customers can now more easily see and understand their\nprogram benefits. Net pricing is clearly visible at the time of ordering and\nreflects savings based on loyalty benefits earned through APP status.\nPractices can also track APP status and upgrade progress in real time.\n * Rewarding Growth: New Portfolio Levels reward growth across the Allergan\nAesthetics portfolio and allow customers to begin earning pricing benefits\nsooner, based on purchasing volume. Eligible purchases across the portfolio\ncount toward higher APP discounts, helping practices unlock greater benefits\nas they grow. New rewards benefits are available for specific customer\nsegments, including first-time APP members, growing practices, and\nlong-standing loyal customers.\nAdditional BOTOX(®) Cosmetic Growth Benefit\n\nAllergan Aesthetics is also introducing a new BOTOX(®) Cosmetic\n(onabotulinumtoxinA) Growth Benefit for eligible customers that recognizes\npractices achieving qualifying quarterly growth by providing a quarterly\nrebate on eligible BOTOX(®) Cosmetic purchases. The Growth Benefit is\ndesigned as an additional way to support customer growth and strengthen\npartnership with Allergan Aesthetics.\n\nAbout Allergan Partner Privileges(®\n)APP is the customer portfolio loyalty program by Allergan Aesthetics designed\nto reward and empower aesthetics practices. Through APP, customers can earn\nsavings, rewards, and benefits across the Allergan Aesthetics portfolio while\ngrowing their business with a trusted industry partner.\n\nAbout Allergan Aesthetics\nAt Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market\na portfolio of leading aesthetics brands and products. Our aesthetics\nportfolio includes facial injectables, body contouring, plastics, skin care,\nand more. Our goal is to consistently provide our customers with innovation,\neducation, exceptional service, and a commitment to excellence, all with a\npersonal touch. For more information, visit www.allerganaesthetics.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=1081228776&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4706707-1%26h%3D1904554432%26u%3Dhttps%253A%252F%252Fedge.prnewswire.com%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D4606759-1%2526h%253D1506431868%2526u%253Dhttps%25253A%25252F%25252Fc212.net%25252Fc%25252Flink%25252F%25253Ft%25253D0%252526l%25253Den%252526o%25253D4354416-1%252526h%25253D2203297917%252526u%25253Dhttps%2525253A%2525252F%2525252Fc212.net%2525252Fc%2525252Flink%2525252F%2525253Ft%2525253D0%25252526l%2525253Den%25252526o%2525253D4147252-1%25252526h%2525253D3391859501%25252526u%2525253Dhttp%252525253A%252525252F%252525252Fwww.allerganaesthetics.com%252525252F%25252526a%2525253Dwww.allerganaesthetics.com%252526a%25253Dwww.allerganaesthetics.com%2526a%253Dwww.allerganaesthetics.com%26a%3Dwww.allerganaesthetics.com&a=www.allerganaesthetics.com)\n.\n\nAbout AbbVie\nAbbVie's mission is to discover and deliver innovative medicines and solutions\nthat solve serious health issues today and address the medical challenges of\ntomorrow. We strive to have a remarkable impact on people's lives across\nseveral key therapeutic areas including immunology, neuroscience and oncology\n– and products and services in our Allergan Aesthetics portfolio. For more\ninformation about AbbVie, please visit us at www.abbvie.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=2855392446&u=http%3A%2F%2Fwww.abbvie.com%2F&a=www.abbvie.com)\n. Follow @abbvie on LinkedIn,\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=3248653038&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fabbvie%2F&a=LinkedIn%2C)\n Facebook\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=2692782220&u=https%3A%2F%2Fwww.facebook.com%2FAbbVieGlobal%2F&a=Facebook)\n, Instagram\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=4238858922&u=https%3A%2F%2Fwww.instagram.com%2Fabbvie%2F&a=Instagram)\n, X\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=2737110622&u=https%3A%2F%2Ftwitter.com%2Fabbvie&a=X)\n and YouTube.\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=302839011&u=https%3A%2F%2Fwww.youtube.com%2Fuser%2FAbbVie&a=YouTube.)\n\nApproved Uses\nBOTOX(®) Cosmetic is a prescription medicine that is injected into muscles\nand used to temporarily improve the look of moderate to severe forehead lines,\ncrow's feet lines, frown lines between the eyebrows, and vertical bands\nconnecting the jaw and neck (platysma bands) in adults.\n\nFor more information, refer to the Medication Guide or talk with your doctor.\nTo report a side effect, please call Allergan Aesthetics at 1-800-678-1605.\n\nSee BOTOX(®) Cosmetic full Product Information\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=583908942&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4658012-1%26h%3D82476651%26u%3Dhttps%253A%252F%252Fwww.rxabbvie.com%252Fpdf%252Fbotox-cosmetic_pi.pdf%26a%3DProduct%2BInformation&a=Product+Information)\n, including Boxed Warning and Medication Guide\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4749777-1&h=140212173&u=https%3A%2F%2Fedge.prnewswire.com%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4658012-1%26h%3D2073419461%26u%3Dhttps%253A%252F%252Fwww.rxabbvie.com%252Fpdf%252Fbotox_medguide.pdf%26a%3DMedication%2BGuide&a=Medication+Guide)\n.\n\nIMPORTANT SAFETY INFORMATION\nBOTOX(®) Cosmetic may cause serious side effects that can be life\nthreatening. Get medical help right away if you have any of these problems any\ntime (hours to weeks) after injection of BOTOX(®) Cosmetic:\n\n * Problems swallowing, speaking, or breathing, due to weakening of associated\nmuscles, which can be severe and result in loss of life. You are at the\nhighest risk if these problems are preexisting before injection. Swallowing\nproblems may last for several months.\n * Spread of toxin effects. The effect of botulinum toxin may affect areas away\nfrom the injection site and cause serious symptoms, including loss of strength\nand all-over muscle weakness, double vision, blurred vision and drooping\neyelids, hoarseness or change or loss of voice, trouble saying words clearly,\nloss of bladder control, trouble breathing, and trouble swallowing.\nBOTOX(®) Cosmetic dosing units are not the same as, or comparable to, any\nother botulinum toxin product.\n\nThere has not been a confirmed serious case of spread of toxin effect when\nBOTOX(®) Cosmetic has been used at the recommended dose to treat frown lines,\ncrow's feet lines, forehead lines, and/or platysma bands.\n\nBOTOX(®) Cosmetic may cause loss of strength or general muscle weakness,\nvision problems, or dizziness within hours to weeks of receiving BOTOX(®)\nCosmetic. If this happens, do not drive a car, operate machinery, or do other\ndangerous activities.\n\nSerious and/or immediate allergic reactions have been reported, including\nitching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or\nfeeling faint. Get medical help right away if you are wheezing or have asthma\nsymptoms, or if you become dizzy or faint.\n\nDo not receive BOTOX(®) Cosmetic if you are allergic to any of the\ningredients in BOTOX(®) Cosmetic (see Medication Guide for ingredients); had\nan allergic reaction to any other botulinum toxin product such as Myobloc\n(rimabotulinumtoxinB), Dysport (abobotulinumtoxinA), Xeomin\n(incobotulinumtoxinA), Jeuveau (prabotulinumtoxinA-xvfs), Daxxify\n(daxibotulinumtoxinA-lanm), or Letybo (letibotulinumtoxinA-wlbg); or have a\nskin infection at the planned injection site. This list may not include all\navailable botulinum toxin products.\n\nTell your doctor about all your muscle or nerve conditions, such as ALS or\nLou Gehrig's disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may\nbe at increased risk of serious side effects, including difficulty swallowing\nand difficulty breathing, from standard doses of BOTOX(®) Cosmetic.\n\nTell your doctor about all your medical conditions, including surgery or plans\nto have surgery on your face, trouble raising your eyebrows, drooping eyelids,\nany other abnormal facial change, are pregnant or plan to become pregnant (it\nis not known if BOTOX(®) Cosmetic can harm your unborn baby), or are\nbreastfeeding or plan to (it is not known if BOTOX(®) Cosmetic passes into\nbreast milk).\n\nTell your doctor about all the medicines you take, including prescription and\nover-the-counter medicines, vitamins, and herbal supplements. Using BOTOX(®)\nCosmetic with certain other medicines may cause serious side effects. Do not\nstart any new medicines until you have told your doctor that you have received\nBOTOX(®) Cosmetic in the past.\n\nTell your doctor if you have received any other botulinum toxin product in the\nlast 4 months; have received injections of botulinum toxin such as Myobloc,\nDysport, Xeomin, Jeuveau, Daxxify, or Letybo in the past (tell your doctor\nexactly which product you received); have recently received an antibiotic by\ninjection; take muscle relaxants; take an allergy or cold medicine; take a\nsleep medicine; or take aspirin-like products or blood thinners.\n\nOther side effects of BOTOX(®) Cosmetic include dry mouth; discomfort or\npain at the injection site; tiredness; headache; neck pain; and eye problems,\nincluding double vision, blurred vision, decreased eyesight, drooping eyelids\nand eyebrows, swelling of eyelids, and dry eyes.\n\nForward-Looking Statements\nSome statements in this news release are, or may be considered,\nforward-looking statements for purposes of the Private Securities Litigation\nReform Act of 1995. The words \"believe,\" \"expect,\" \"anticipate,\" \"project\" and\nsimilar expressions and uses of future or conditional verbs, generally\nidentify forward-looking statements. AbbVie cautions that these\nforward-looking statements are subject to risks and uncertainties that may\ncause actual results to differ materially from those expressed or implied in\nthe forward-looking statements. Such risks and uncertainties include, but are\nnot limited to, challenges to intellectual property, competition from other\nproducts, difficulties inherent in the research and development process,\nadverse litigation or government action, changes to laws and regulations\napplicable to our industry, the impact of global macroeconomic factors, such\nas economic downturns or uncertainty, international conflict, trade disputes\nand tariffs, and other uncertainties and risks associated with global business\noperations. Additional information about the economic, competitive,\ngovernmental, technological and other factors that may affect AbbVie's\noperations is set forth in Item 1A, \"Risk Factors,\" of AbbVie's 2025 Annual\nReport on Form 10-K, which has been filed with the Securities and Exchange\nCommission, as updated by its Quarterly Reports on Form 10-Q and in other\ndocuments that AbbVie subsequently files with the Securities and Exchange\nCommission that update, supplement or supersede such information. AbbVie\nundertakes no obligation, and specifically declines, to release publicly any\nrevisions to forward-looking statements as a result of subsequent events or\ndevelopments, except as required by law.\n\nU.S. Media:\nAdelle Infante, Corporate Communications\nadelle.infante@allergan.com (mailto:adelle.infante@allergan.com)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/allergan-aesthetics-refreshes-allergan-partner-privileges-to-better-support-todays-modern-aesthetics-practices-302847863.html\n(https://www.prnewswire.com/news-releases/allergan-aesthetics-refreshes-allergan-partner-privileges-to-better-support-todays-modern-aesthetics-practices-302847863.html)\n\nSOURCE AbbVie\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-08-11T12:00:14.279439281Z","server_sent_at_ms":1786449614279},"received_at":"2026-08-11T12:00:14.456Z","source_url":"https://www.prnewswire.com/news-releases/allergan-aesthetics-refreshes-allergan-partner-privileges-to-better-support-todays-modern-aesthetics-practices-302847863.html"},"analysis":{"id":"104356","press_release_id":"115347","analysis_json":{"industry":{"label":"Pharmaceuticals","sector":"Health Care"},"redFlags":[],"eventType":"operations_update","narrative":"Allergan Aesthetics, an AbbVie company, has updated its Allergan Partner Privileges (APP) loyalty program to simplify savings and increase transparency for aesthetics practices.\n\nThe refresh introduces new rewards for first-time members, growing practices, and loyal customers, aiming to make it easier to maximize the value of the partnership.\n\nAdditionally, a new BOTOX Cosmetic Growth Benefit will provide a quarterly rebate to eligible practices that achieve qualifying growth targets.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"AbbVie's Allergan Aesthetics refreshes loyalty program to drive practice growth and retention."},"keyFigures":{},"quotedText":"The needs of today's aesthetics practices continue to evolve, and so should the programs designed to support them","namedEntities":{"people":[{"name":"Nicole Mowad-Nassar","role":"Senior Vice President, AbbVie and President, Global Allergan Aesthetics"}],"products":["Allergan Partner Privileges","BOTOX Cosmetic","onabotulinumtoxinA"],"companies":[{"name":"Allergan Aesthetics","relationship":"subsidiary"},{"name":"AbbVie","ticker":"ABBV","relationship":"parent company"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"The refresh of a loyalty program is a standard operational improvement designed to support customer retention and growth. While positive for business momentum, it does not represent a material financial surprise or binary event."},"tickerRelevance":{"others":[],"primary":"ABBV"},"globalImportance":20,"audienceRelevance":30,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap","eventGravity":"operational_update","sectorWeight":"health_care"}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Allergan Aesthetics, an AbbVie company, has updated its Allergan Partner Privileges (APP) loyalty program to simplify savings and increase transparency for aesthetics practices.\n\nThe refresh introduces new rewards for first-time members, growing practices, and loyal customers, aiming to make it easier to maximize the value of the partnership.\n\nAdditionally, a new BOTOX Cosmetic Growth Benefit will provide a quarterly rebate to eligible practices that achieve qualifying growth targets.","key_figures":{},"named_entities":{"people":[{"name":"Nicole Mowad-Nassar","role":"Senior Vice President, AbbVie and President, Global Allergan Aesthetics"}],"products":["Allergan Partner Privileges","BOTOX Cosmetic","onabotulinumtoxinA"],"companies":[{"name":"Allergan Aesthetics","relationship":"subsidiary"},{"name":"AbbVie","ticker":"ABBV","relationship":"parent company"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-11T15:53:21.660Z","global_importance":20,"audience_relevance":30,"importance_components":{"tickerTier":"large-cap","eventGravity":"operational_update","sectorWeight":"health_care"}},"durationMs":825352,"modelName":"glm-4.7"}}